Exelixis, Inc. (EXEL) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Exelixis, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.198 Good day, ladies and gentlemen, and welcome to the Exelixis second quarter 2025 00:00:05.198 -- 00:00:10.365 financial results conference call. My name is Tawanda, and I'll be your operator 00:00:10.365 -- 00:00:16.193 for today. As a reminder, this call is being recorded for replay purposes. 00:00:16.193 -- 00:00:19.217 I would now like to turn the call over to your host for today, Ms. 00:00:19.217 -- 00:00:24.224 Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. 00:00:24.224 -- 00:00:26.086 Please proceed. 00:00:26.086 -- 00:00:30.090 Thank you, Tawanda, and thank you all for joining us for the Exalexis Second Quarter 00:00:30.090 -- 00:00:35.255 2025 Financial Results Conference Call. Joining me on today's call are Mike 00:00:35.255 -- 00:00:40.520 Morrissey, our President and CEO, Chris Senner, our Chief Financial Officer, PJ Haley, 00:00:40.520 -- 00:00:45.185 our Executive Vice President of Commercial, Amy Peterson, our Chief Medical Officer, 00:00:45.185 -- 00:00:49.710 and Dana Aftab, our Chief Scientific Officer, who will review our progress for the second 00:00:49.710 -- 00:00:53.947 quarter 2025 and in June 30th, 2025. 00:00:53.947 -- 00:00:58.534 During the call today, we will refer to financial measures not calculated according to 00:00:58.534 -- 00:01:02.701 generally accepted accounting principles. Please refer to today's press release, which 00:01:02.701 -- 00:01:07.388 is posted on our website, for an explanation of our reasons for using such non-GAAP measures, 00:01:07.388 -- 00:01:10.833 as well as tables deriving these measures from our GAAP results. 00:01:10.833 -- 00:01:14.078 During the course of this presentation, we will be making forward-looking statements 00:01:14.078 -- 00...